Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Shuttle Effect : Combination Therapy With Deferiprone and Deferasirox in Transfusion-dependent Thalassemia Patients.

NCT02198508 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT02198508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02198508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Shuttle Effect : Combination Therapy With Deferiprone and Deferasirox in Transfusion-dependent Thalassemia Patients.
Lead sponsor
China Medical University Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2007
Completion date
Not reported
Enrollment
13 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

beta-thalassemia major